C07C 243/26
With acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon
Official title: with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
C07C243/26 (With acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon) appears on 291 US grants and 215 published applications in this corpus.
Search patents in C07C- Granted patents
- 291
- Published applications
- 215
- Assignees
- 196
- Inventors
- 750
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 5 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 11 | 0 |
| 1996 | 11 | 0 |
| 1997 | 15 | 0 |
| 1998 | 4 | 0 |
| 1999 | 10 | 0 |
| 2000 | 6 | 0 |
| 2001 | 9 | 1 |
| 2002 | 5 | 8 |
| 2003 | 7 | 6 |
| 2004 | 2 | 11 |
| 2005 | 5 | 5 |
| 2006 | 7 | 7 |
| 2007 | 5 | 4 |
| 2008 | 5 | 6 |
| 2009 | 2 | 6 |
| 2010 | 6 | 9 |
| 2011 | 1 | 4 |
| 2012 | 5 | 11 |
| 2013 | 7 | 12 |
| 2014 | 13 | 13 |
| 2015 | 12 | 14 |
| 2016 | 8 | 11 |
| 2017 | 18 | 19 |
| 2018 | 4 | 9 |
| 2019 | 10 | 9 |
| 2020 | 8 | 4 |
| 2021 | 5 | 9 |
| 2022 | 4 | 10 |
| 2023 | 6 | 12 |
| 2024 | 3 | 5 |
| 2025 | 5 | 6 |
| 2026 | 7 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Reagent for mass spectrometry29 Sep 2026US 12,748,116 B2Roche Diagnostics Operations, Inc.
- Precursor compounds of ester compounds16 Jun 2026US 12,655,092 B2University of Guelph
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Reduced graphene oxide (rGO) based drug carrier systems10 Feb 2026US 12,544,454 B2
- Degradable crosslinking agent10 Sep 2026US 2026/0265184 A1Nagase Chemtex Corporation
- Hiv inhibitor compounds14 May 2026US 2026/0132139 A1Gilead Sciences, Inc.
- (2,4-dichlorophenoxy)acetic acid analogs12 Feb 2026US 2026/0042731 A1Corteva Agriscience LLC
- Perovskite precursor solution, perovskite thin film, perovskite cell and electrical apparatus8 Jan 2026US 2026/0008795 A1Contemporary Amperex Technology Co., Limited
- Plasminogen Activator Inhibitor-1 (PAI-1) Inhibitor and Method of Use13 Nov 2025US 2025/0345293 A1Eastern Michigan University
Most cited
By later US patents
- Neprilysin inhibitors67US 8,449,890 B2Theravance, Inc. · 2013
- Functionalized ionic liquids, and methods of use thereof64US 7,208,605 B2University of South Alabama · 2007
- Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments58US 6,521,431 B1Access Pharmaceuticals, Inc. · 2003
- Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines56US 5,424,333 ARohm and Haas Company · 1995
- Neprilysin inhibitors56US 8,691,868 B2Theravance, Inc. · 2014